Literature DB >> 15301960

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery.

Mei-Chu Lo1, Ann Aulabaugh, Guixian Jin, Rebecca Cowling, Jonathan Bard, Michael Malamas, George Ellestad.   

Abstract

The fluorescence-based thermal shift assay is a general method for identification of inhibitors of target proteins from compound libraries. Using an environmentally sensitive fluorescent dye to monitor protein thermal unfolding, the ligand-binding affinity can be assessed from the shift of the unfolding temperature (Delta Tm) obtained in the presence of ligands relative to that obtained in the absence of ligands. In this article, we report that the thermal shift assay can be conducted in an inexpensive, commercially available device for temperature control and fluorescence detection. The binding affinities obtained from thermal shift assays are compared with the binding affinities measured by isothermal titration calorimetry and with the IC(50) values from enzymatic assays. The potential pitfalls in the data analysis of thermal shift assays are also discussed.

Mesh:

Substances:

Year:  2004        PMID: 15301960     DOI: 10.1016/j.ab.2004.04.031

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  251 in total

1.  The polypeptide binding conformation of calreticulin facilitates its cell-surface expression under conditions of endoplasmic reticulum stress.

Authors:  Elise Jeffery; Larry Robert Peters; Malini Raghavan
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.

Authors:  Sayaka Shibata; J Robert Gillespie; Ranae M Ranade; Cho Yeow Koh; Jessica E Kim; Joy U Laydbak; Frank H Zucker; Wim G J Hol; Christophe L M J Verlinde; Frederick S Buckner; Erkang Fan
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

3.  Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening.

Authors:  Yi Wen; Lei Xu; Fang-lei Chen; Jing Gao; Jing-ya Li; Li-hong Hu; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

4.  Ligand binding analysis and screening by chemical denaturation shift.

Authors:  Arne Schön; Richard K Brown; Burleigh M Hutchins; Ernesto Freire
Journal:  Anal Biochem       Date:  2013-08-29       Impact factor: 3.365

Review 5.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

6.  Structure of the effector-binding domain of the arabinose repressor AraR from Bacillus subtilis.

Authors:  Kateřina Procházková; Kateřina Cermáková; Petr Pachl; Irena Sieglová; Milan Fábry; Zbyszek Otwinowski; Pavlína Rezáčová
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-01-17

7.  FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2018-10-16       Impact factor: 4.956

Review 8.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

9.  High-throughput thermal scanning: a general, rapid dye-binding thermal shift screen for protein engineering.

Authors:  Jason J Lavinder; Sanjay B Hari; Brandon J Sullivan; Thomas J Magliery
Journal:  J Am Chem Soc       Date:  2009-03-25       Impact factor: 15.419

10.  Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway.

Authors:  Natasha Del Cid; Elise Jeffery; Syed Monem Rizvi; Ericca Stamper; Larry Robert Peters; William Clay Brown; Chester Provoda; Malini Raghavan
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.